Central Trust Company’s LeMaitre Vascular LMAT Stock Holding History

Central Trust Company’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.4K	Buy	22 +15	+214%	+$1.43K	﹤0.01%	1350
2025 Q4	$568	Buy	+7	New	+$603	﹤0.01%	1431
2024 Q1	–	Sell	-56	Closed	-$3.18K	–	1399
2023 Q4	$3.18K	Hold	56	–	–	﹤0.01%	1227
2023 Q3	$3.05K	Hold	56	–	–	﹤0.01%	1213
2023 Q2	$3.77K	Hold	56	–	–	﹤0.01%	1124
2023 Q1	$2.88K	Hold	56	–	–	﹤0.01%	1163
2022 Q4	$2.58K	Hold	56	–	–	﹤0.01%	1137
2022 Q3	$3K	Hold	56	–	–	﹤0.01%	1161
2022 Q2	$3K	Hold	56	–	–	﹤0.01%	1171
2022 Q1	$3K	Buy	+56	New	+$2.51K	﹤0.01%	1210

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Central Trust Company's LMAT Position: Q1 2026 in Review

Central Trust Company increased its LeMaitre Vascular (LMAT) stake by 214% in Q1 2026, buying an estimated $1.43K and bringing the position to 22 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1350.

Central Trust Company first reported a position in LMAT in Q1 2022 and has held it in 10 quarters since. The position peaked at $3.77K in Q2 2023. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Central Trust Company held 22 shares of LeMaitre Vascular worth $2.4K as of Q1 2026.
Central Trust Company bought 15 LeMaitre Vascular shares in Q1 2026, an estimated $1.43K.
LeMaitre Vascular made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #1350 holding.
Central Trust Company first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 10 quarters since.
Central Trust Company's LeMaitre Vascular position peaked at $3.77K in Q2 2023.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.